Blood-and-Bone-Conditions

Is Pharmacyclics the Next Celgene?

Pharmacyclics has made a big move in the past two years as investors have become increasingly excited by the potential for Imbruvica,...

Verastem Inc.'s Upcoming Catalysts

Verastem is having its annual research and development day in a few weeks, on July 10. Call it a catalyst to announce catalysts. We...

Why NeoStem, Inc. Shares Popped

Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in...